India to Bangladesh: Rifampicin Export Trade Route
India has recorded 39 verified shipments of Rifampicin exported to Bangladesh, representing a combined trade value of $96.2M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $2.5M USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD, which accounts for 97% of total export value with 14 shipments worth $93.5M USD. On the buying side, DIRECTOR MBDC DGHS is the largest importer in Bangladesh with $87.2M USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LTD , LUPIN LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Bangladesh Rifampicin corridor is one of India's established pharmaceutical export routes, with 39 shipments documented worth a combined $96.2M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's rifampicin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $2.5M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with rifampicin's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 25.0%, placing it at rank #3 among India's top rifampicin export destinations globally.
On the import side, key buyers of Indian rifampicin in Bangladesh include DIRECTOR MBDC DGHS, WORLD HEALTH ORGANIZATION (BANGLADE, DIRECTOR MBDC DGHS and 7 others. DIRECTOR MBDC DGHS is the single largest importer with 1 shipments valued at $87.2M USD.
